News
Media
Academy
Conferences
Publications
CME/CE
Job Board
Subscribe
Directories

Spotlight -

Concierge Medicine Forum|

|Videos|October 7, 2021

The levels of HIE involvement

Author(s)Jeff Bendix, Senior Editor, Logan Lutton

Physicians can use HIEs in two ways.

Christopher Hobson, M.D., says physicians can use HIEs either just to receive data, or more fully by contributing data to the HIE and/or participating in care coordination programs.

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Related Content

© Emory University

ACIP presentation focuses on potential vaccine harm while ignoring benefits, physician expert says

ByRichard Payerchin

December 11th 2025

Flow Neuroscience gets approval for depression treatment device: ©Flow Neurosciences

Flow Neuroscience wins first FDA approval for at-home brain-stimulation depression treatment

December 11th 2025

Off the Chart: A Business of Medicine Podcast - Ep. 109: Point-of-care testing with Daniel Krajcik, D.O., MBA

Point-of-care testing, with Daniel Krajcik, D.O., MBA

ByAustin Littrell

December 11th 2025

Morning Medical Update © kwanchaichaiudom - stock.adobe.com

Sperm donor with rare cancer-causing gene fathered nearly 200 children in Europe; FDA’s priority voucher delivers first approval; mobile DNA and lung tumors – Morning Medical Update

ByAustin Littrell

December 11th 2025

Hospitals seeing rising costs: ©MedicalWorks - stock.adobe.com

Hospitals confront rising non-labor costs, workforce pressures and reimbursement challenges, Kaufman Hall reports

December 10th 2025

Latest CME

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

In-Person + Virtual Event

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

January 23, 2026

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Medical Economics

Flow Neuroscience wins first FDA approval for at-home brain-stimulation depression treatment

Protected EHR time cuts after-hours work with little productivity loss, study finds

ACIP presentation focuses on potential vaccine harm while ignoring benefits, physician expert says

The importance of estate planning

Hospitals confront rising non-labor costs, workforce pressures and reimbursement challenges, Kaufman Hall reports

© 2025 MJH Life Sciences^®

All rights reserved.